Clinical features and outcomes of patients with myositis associated-interstitial lung disease
T. Karampitsakos (Patras, Greece), O. Papaioannou (Patras, Greece), S. Chrysikos (Athens, Greece), M. Katsaras (Patras, Greece), G. Tsirikos (Patras, Greece), P. Tsiri (Patras, Greece), E. Zarkadi (Patras, Greece), P. Efthymiou (Patras, Greece), V. Sotiropoulou (Patras, Greece), N. Ntoulias (Patras, Greece), E. Malakounidou (Patras, Greece), A. Bellou (Patras, Greece), V. Tzilas (Athens, Greece), E. Bouros (Athens, Greece), F. Sampsonas (Patras, Greece), T. Karageorgas (Athens, Greece), K. Dimakou (Athens, Greece), D. Bouros (Athens, Greece), A. Tzouvelekis (Patras, Greece)
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Karampitsakos (Patras, Greece), O. Papaioannou (Patras, Greece), S. Chrysikos (Athens, Greece), M. Katsaras (Patras, Greece), G. Tsirikos (Patras, Greece), P. Tsiri (Patras, Greece), E. Zarkadi (Patras, Greece), P. Efthymiou (Patras, Greece), V. Sotiropoulou (Patras, Greece), N. Ntoulias (Patras, Greece), E. Malakounidou (Patras, Greece), A. Bellou (Patras, Greece), V. Tzilas (Athens, Greece), E. Bouros (Athens, Greece), F. Sampsonas (Patras, Greece), T. Karageorgas (Athens, Greece), K. Dimakou (Athens, Greece), D. Bouros (Athens, Greece), A. Tzouvelekis (Patras, Greece). Clinical features and outcomes of patients with myositis associated-interstitial lung disease. 2246
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Clinical characteristics of anti-Jo-1-positive interstitial lung disease Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new? Year: 2019
Clinical features and prognosis of Chinese sarcoidosis patients. Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management Year: 2018
Clinical features of patients with sarcoidosis associated with Sjogren‘s syndrome Source: Eur Respir J 2005; 26: Suppl. 49, 32s Year: 2005
Eosinophilic lung disease: clinical features of 25 patients Source: Eur Respir J 2006; 28: Suppl. 50, 237s Year: 2006
Clinical features of interstitial lung disease in polymyositis and dermatomyositis Source: Eur Respir J 2006; 28: Suppl. 50, 828s Year: 2006
Rheumatoid arthritis-related interstitial lung disease (RA-ILD): Clinical, functional features, and variables associated poor initial prognosis in a chilean cohort Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children Year: 2020
Difference of the clinical characteristics and outcome between interstitial lung disease with dermatomyositis and idiopathic interstitial pneumonia Source: International Congress 2017 – Lung function testing Year: 2017
Clinical features and outcome of patients with acute exacerbation of interstitial pneumonia associated with collagen vascular disease Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis Year: 2010
Clinical features and outcome of COVID-19 pneumonia in haemodialysis patients Source: Virtual Congress 2021 – Diagnosis and management of COVID-19 Year: 2021
Incidence, clinical manifestations and prognosis of cardiac sarcoidosis in patients with pulmonary sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013
Clinical characteristics of patients with unclassifiable interstitial lung disease Source: International Congress 2015 – New insights into IIPs Year: 2015
The features of patients with sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 436s Year: 2002
Interstitial lung disease with ANCA-associated vasculitis (AAV-ILD): Clinical features and survival compared to patients with ILD associated with systemic sclerosis and IPF Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020
Clinical and morphological signs of liver damadge in patients with pulmonary sarcoidosis Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders Year: 2011
Clinical and functional characteristics of patients with unclassifiable interstitial lung diseases (uILD) from eurIPFreg. Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020
The features of sarcoidosis in owerweight patients. Source: Virtual Congress 2021 – Moving forward in various aspects of sarcoidosis Year: 2021
The characteristics of mycobacterioses in patients with chronic lung diseases Source: International Congress 2019 – Airway infection in COPD Year: 2019
SW13,15,17 Clinical, radiological and pathological correlations in lung diseases Source: Milan 2017 - Educational material Year: 2017
Interstitial pneumonia with autoimmune features associated with myositis autoantibodies: clinical characteristics from a multicenter Latin-American cohort. Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019
Features of tuberculosis incidence and clinical forms for sarcoidosis patients Source: Eur Respir J 2004; 24: Suppl. 48, 202s Year: 2004